Atlas Trials

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

Clinical trial NCT06949319 · RECRUITING

Trial details

NCT number
NCT06949319
Sponsor
Nedim Tojaga
Status
RECRUITING
Study type
OBSERVATIONAL
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Atrial Fibrillation New OnsetNon Valvular Atrial FibrillationStroke (in Patients With Atrial Fibrillation)StrokeThrombosis
Start date
2024-08-16
Primary completion
2025-09-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.